GlassScriptPhysician profile
Christopher Chase Davis
NPI 1962058867
$1,748.74
in general payments reported to CMS, 2019-2025
14 companies · $1,294 in 2025
The $1,294 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.80 · 2022: $66.67 · 2023: $49.75 · 2024: $254 · 2025: $1,294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $896 · Food and Beverage: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $895.58 |
| Food and Beverage | $701.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,075.46 | 2021-2025 | Linq II |
| Amgen INC. | $157.21 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $146.29 | 2021-2025 | Lifevest |
| Philips North America LLC | $102.47 | 2024-2025 | Ecc Solutions, (Ck7) Extended Holter, (Ck4) Mcot |
| Boston Scientific Corporation | $48.58 | 2024-2025 | Bodyguardian |
| Kiniksa Pharmaceuticals International, Plc | $39.36 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $39.26 | 2025 | Verquvo |
| Vapotherm INC | $29.70 | 2022 | |
| Abbvie INC. | $29.50 | 2021 | |
| Irhythm Technologies, INC. | $22.75 | 2024 | Zio Monitor, Zio Xt Patch |
| Novo Nordisk INC | $18.70 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.76 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $13.44 | 2024 | Eliquis |
| Vivaquant INC, Dba Rhythm Express | $9.26 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.